Implemed Anticipating Olimpicc 510(k) Clearance By Year-End
This article was originally published in The Gray Sheet
Executive Summary
Implemed's 510(k) for the Olimpicc antimicrobial peripherally inserted central venous catheter should be cleared by the end of the year, the company says. Alongside data from an initial safety study, the submission, currently in development, will include results from two ongoing European trials that are evaluating the device's antimicrobial effectiveness.